DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Stallion India Fluorochemicals Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2 hrs ago·28 Sept 2026, 1:13 pm

Stallion IND Fluorochem L

Stallion India Fluorochemicals Limited has announced that it is scheduled to hold an analyst and institutional investor meet. The company has informed the stock exchange about the details of this upcoming event, which is a standard procedure for publicly traded firms to engage with the market.

This meeting is significant for investors as it provides a platform for the company's management to discuss its business strategy, financial performance, and future outlook directly with the investment community. It offers an opportunity for the company to address key questions and share insights that are not typically available in public filings.

Investors should watch for updates on the company's production capacity, order book, and any guidance provided regarding its growth trajectory. The market will closely monitor the management's commentary to gauge the company's operational health and potential for future expansion.